|
|
||||||||||
|
J Am Coll Cardiol, 2004; 43:1034-1041, doi:10.1016/j.jacc.2003.08.063 © 2004 by the American College of Cardiology Foundation |





* Department of Cardiology, Stanford University, Stanford, California, USA
Cardiovascular Division, Department of Clinical Pathophysiology, Nagoya, Japan
Department of Cardiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan
Nagoya University School of Health Sciences, Nagoya, Japan
Manuscript received December 3, 2002; revised manuscript received June 10, 2003, accepted August 26, 2003.
* Reprint requests and correspondence: Dr. Hannah A. Valantine, Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Falk CVRC, Stanford, California 94305-5406, USA.
hvalantine{at}stanford.edu
OBJECTIVES: The possible effect of plasma hemoglobin A1c (HbA1c) on the development of transplant coronary artery disease (TxCAD) was investigated.
BACKGROUND: Glucose intolerance is implicated as a risk factor for TxCAD. However, a relationship between HbA1c and TxCAD has not been demonstrated.
METHODS: Plasma HbA1c was measured in 151 adult patients undergoing routine annual coronary angiography at a mean period of 4.1 years after heart transplantation. Intracoronary ultrasound (ICUS) was also performed in 42 patients. Transplant CAD was graded by angiography as none, mild (stenosis in any vessel
30%), moderate (31% to 69%), or severe (
70%) and was defined by ICUS as a mean intimal thickness (MIT)
0.3 mm in any coronary artery segment. The association between TxCAD and established risk factors was examined.
RESULTS: Plasma HbA1c increased with the angiographic grade of TxCAD (5.6%, 5.8%, 6.4%, and 6.2% for none, mild, moderate, and severe disease, respectively; p < 0.05 for none vs. moderate or severe) and correlated with disease severity (r = 0.24, p < 0.05). The HbA1c level was higher in patients with MIT
0.3 mm than in those with MIT <0.3 mm (6.4% vs. 5.7%, p < 0.05). Multivariate logistic regression analysis identified HbA1c as an independent predictor of TxCAD, as detected by angiography or ICUS (odds ratios 1.9 and 2.4, 95% confidence intervals 1.5 to 6.3 [p = 0.010] and 1.3 to 4.2 [p < 0.005], respectively).
CONCLUSIONS: Persistent glucose intolerance, as reflected by plasma HbA1c, is associated with the occurrence of TxCAD and may play an important role in its pathogenesis.
| ||||||||||||||||||||||
This article has been cited by other articles:
![]() |
J. B. L. Hoekstra, F. Holleman, and H. DeVries Glucose Tolerance Testing in Patients Scheduled for Cardiovascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 7 - 9. [Abstract] [PDF] |
||||
![]() |
V. Menon, T. Greene, A. A. Pereira, X. Wang, G. J. Beck, J. W. Kusek, A. J. Collins, A. S. Levey, and M. J. Sarnak Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3411 - 3417. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |